Maxim Group Starts TrovaGene (TROV) at Buy, $12 PT
Tweet Send to a Friend
Maxim Group initiates coverage on TrovaGene (NASDAQ: TROV) with a Buy rating and a price target of $12.00.Analyst Jason Kolbert ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE